«While we endorse annual mammography for all women age 40 and over, and the addition of annual MRI for women at high risk, MBI fills an important gap for supplemental screening in
women with dense breasts who are not otherwise at high risk.»
Not exact matches
The study, conducted at Mayo Clinic, included 1,585
women with heterogeneously or extremely
dense breasts who underwent an MBI exam at the time of their screening mammogram.
A new study, conducted at Mayo Clinic, included 1,585
women with heterogeneously or extremely
dense breasts who underwent an MBI exam at the time of their screening mammogram.
«Our findings highlight the potential value for a randomized controlled trial of aspirin as an agent in early detection of
breast cancer, particularly for
women with naturally
dense tissues
who may be at an increased risk for certain cancers,» said Despina Kontos, PhD, assistant professor of Radiology, and co-author on the study.
The NPV was 99.1 percent in
women who had
dense breasts and 99.3 in
women with non-
dense tissue, providing confirmation that when a
woman receives a negative test result, she does not have
breast cancer.
«Early evidence suggests that tomosynthesis may be a promising tool for
women with dense breasts that may reduce false positives,» said Christoph Lee, associate professor of radiology at the University of Washington School of Medicine,
who contributed to the study.
Examples of higher risk would include
women who carry a strong genetic predisposition to
breast cancer, such as carriers of a BRCA1 or BRCA2 mutation, or
woman with dense breasts (making mammography difficult)
who have a first degree relative
with breast cancer.